Exact Sciences Corp
EXASDelisted Mar 23, 2026- Industry
- Services-Medical Laboratories
- SEC CIK
- 0001124140
Exact Sciences Corp was delisted on Mar 23, 2026; its insiders filed their last Form 4 on Mar 23, 2026; 712 institutions reported holding it in 13F filings for Q4 2025, worth $17.9B in total; superinvestors Soros Fund Management and ARK Invest held it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by Exact Sciences Corp insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 0 filings
- Open-market sells
- 0 filings
- Insiders trading
- 0
- Net value
- $0
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for Exact Sciences Corp, current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Coward D Scott | Director | 0Indirect | Mar 23, 2026 | 1 |
| Orville Jacob A | EVP, GM, Screening | 0Indirect | Mar 23, 2026 | 4 |
| Trigg Leslie | Director | 0 | Mar 23, 2026 | 1 |
| Conroy Kevin T | President and CEO | 0Indirect | Mar 23, 2026 | 4 |
| Popovits Kimberly J | Director | 0 | Mar 23, 2026 | 1 |
| Zanotti Katherine S | Director | 0 | Mar 23, 2026 | 2 |
| Clancy Paul J | Director | 0 | Mar 23, 2026 | 1 |
| Doyle James Edward | Director | 0 | Mar 23, 2026 | 2 |
| Petrovic Shacey | Director | 0Indirect | Mar 23, 2026 | 1 |
| Condella Sarah | EVP, Human Resources | 0Indirect | Mar 23, 2026 | 4 |
| Barber Michael J | Director | 0 | Mar 23, 2026 | 1 |
| Baranick Brian | EVP, GM, Precision Oncology | 0Indirect | Mar 23, 2026 | 4 |
| Herriott James | SVP, General Counsel & Sec | 0Indirect | Mar 23, 2026 | 6 |
| Bloomer Aaron | EVP, Chief Financial Officer | 0Indirect | Mar 23, 2026 | 3 |
| Levangie Daniel J | Director | 34,312 | Jun 16, 2025 | 0 |
| Sebelius Kathleen | Director | 32,671 | Dec 20, 2024 | 0 |
| Cunningham Everett | Chief Commercial Officer | 47,042 | May 2, 2024 | 0 |
| Elliott Jeffrey Thomas | Chief Financial Officer | 11,795 | May 2, 2024 | 0 |
| Scannell Timothy J | Director | 5,694 | Nov 1, 2023 | 0 |
| Lewis-Hall Freda C | Director | 19,688 | Jun 12, 2023 | 0 |
| Jacquet Pierre | Director | 23,576 | Jun 12, 2023 | 0 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Feb 16, 2023 (view filing) | Feb 15 | 1 day | Coward D ScottDirector | SSale | −1.82K | $65.59 | −$119.4K | −6.4%26.5K after | |
| Feb 16, 2023 (view filing) | Feb 15 | 1 day | Elliott Jeffrey ThomasChief Financial Officer | SSale | −1.87K | $65.59 | −$122.4K | −7.6%22.7K after | |
| Feb 16, 2023 (view filing) | Feb 15 | 1 day | Conroy Kevin TPresident and CEO | SSale | −14.6K | $65.59 | −$958.7K | −1.2%1.19M after | |
| Feb 14, 2023 (view filing) | Feb 13 | 1 day | Elliott Jeffrey ThomasChief Financial Officer | SSale | −1.16K | $64.55 | −$74.7K | −5.3%20.5K after | |
| Feb 14, 2023 (view filing) | Feb 13 | 1 day | Conroy Kevin TPresident and CEO | SSale | −4.53K | $64.55 | −$292.2K | −0.4%1.17M after | |
| Feb 3, 2023 (view filing) | Feb 1 | 2 days | Condella SarahEVP, Human Resources | SSale | −1.00K | $67.93 | −$67.9K | −1.2%84.1K after | |
| Jan 11, 2023 (view filing) | Jan 9 | 2 days | Condella SarahEVP, Human Resources | SSale | −1.00K | $60.00 | −$60.0K | −1.2%85.1K after | |
| Oct 13, 2022 (view filing) | Oct 12 | 1 day | Cunningham EverettChief Commercial Officer | SSale | −16.9K | $31.37 | −$529.3K | −47.5%18.7K after | |
| Aug 8, 2022 (view filing) | Aug 5 | 3 days | Baranick BrianGen. Mgr., Precision Oncology | SSale | −984 | $47.12 | −$46.4K | −17.6%4.60K after | |
| Jul 28, 2022 (view filing) | Jul 26 | 2 days | Zanotti Katherine SDirector | SSale | −4.61K | $45.14 | −$208.0K | −7.1%60.3K after | |
| Jul 6, 2022 (view filing) | Jul 1 | 5 days | Conroy Kevin TPresident and CEO | SSale | −7 | $40.75 | −$285.25 | 0.0%1.17M after | |
| Jul 1, 2022 (view filing) | Jun 30 | 1 day | Zanotti Katherine SDirector | SSale | −1.09K | $40.13 | −$43.6K | −1.8%60.3K after | |
| Mar 2, 2022 (view filing) | Mar 1 | 1 day | Condella SarahEVP, Human Resources | SSale | −2.82K | $76.69 | −$216.0K | −3.2%85.8K after | |
| Mar 2, 2022 (view filing) | Mar 1 | 1 day | Conroy Kevin TPresident and CEO | SSale | −14.3K | $76.69 | −$1.10M | −1.5%931.0K after | |
| Mar 2, 2022 (view filing) | Mar 1 | 1 day | Coward D ScottChief Legal Officer | SSale | −3.91K | $76.69 | −$300.0K | −19.4%16.2K after | |
| Mar 2, 2022 (view filing) | Mar 1 | 1 day | Elliott Jeffrey ThomasChief Financial Officer | SSale | −4.05K | $76.69 | −$310.6K | −17.5%19.1K after | |
| Mar 1, 2022 (view filing) | Feb 25 | 4 days | Condella SarahSVP, Human Resources | SSale | −5.48K | $74.19 | −$406.5K | −6.2%82.7K after | 2 lots |
| Feb 25, 2022 (view filing) | Feb 24 | 1 day | Condella SarahSVP, Human Resources | SSale | −4.72K | $70.10 | −$330.7K | −5.1%88.2K after | |
| Feb 25, 2022 (view filing) | Feb 24 | 1 day | Conroy Kevin TPresident and CEO | SSale | −27.1K | $70.10 | −$1.90M | −2.9%915.4K after | |
| Feb 25, 2022 (view filing) | Feb 24 | 1 day | Coward D ScottChief Administrative Officer | SSale | −5.82K | $70.10 | −$407.6K | −32.9%11.9K after | |
| Feb 25, 2022 (view filing) | Feb 24 | 1 day | Elliott Jeffrey ThomasChief Financial Officer | SSale | −5.90K | $70.10 | −$413.4K | −28.6%14.7K after | |
| Feb 25, 2022 (view filing) | Feb 24 | 1 day | Orville Jacob AGeneral Manager, New Ventures | SSale | −4.72K | $70.10 | −$330.7K | −23.9%15.0K after | |
| Feb 24, 2022 (view filing) | Feb 23 | 1 day | Elliott Jeffrey ThomasChief Financial Officer | SSale | −1.56K | $69.05 | −$107.5K | −16.5%7.87K after | |
| Feb 24, 2022 (view filing) | Feb 23 | 1 day | Condella SarahSVP, Human Resources | SSale | −1.12K | $69.05 | −$77.6K | −1.3%82.7K after | |
| Feb 24, 2022 (view filing) | Feb 23 | 1 day | Conroy Kevin TPresident and CEO | SSale | −5.19K | $69.05 | −$358.2K | −0.6%883.9K after | |
| Feb 24, 2022 (view filing) | Feb 23 | 1 day | Orville Jacob AGeneral Manager, New Ventures | SSale | −1.13K | $69.05 | −$77.7K | −10.5%9.56K after | |
| Feb 24, 2022 (view filing) | Feb 23 | 1 day | Coward D ScottChief Administrative Officer | SSale | −1.11K | $69.05 | −$76.6K | −18.4%4.93K after | |
| Feb 23, 2022 (view filing) | Feb 22 | 1 day | Orville Jacob AGeneral Manager, New Ventures | SSale | −1.75K | $72.72 | −$127.2K | −17.2%8.44K after | |
| Feb 16, 2022 (view filing) | Feb 15 | 1 day | Condella SarahSVP, Human Resources | SSale | −938 | $79.55 | −$74.6K | −1.1%81.6K after | |
| Feb 16, 2022 (view filing) | Feb 15 | 1 day | Elliott Jeffrey ThomasChief Financial Officer | SSale | −1.84K | $79.55 | −$146.3K | −22.6%6.31K after | |
| Feb 16, 2022 (view filing) | Feb 15 | 1 day | Conroy Kevin TPresident and CEO | SSale | −14.4K | $79.55 | −$1.15M | −1.6%878.7K after | |
| Feb 16, 2022 (view filing) | Feb 15 | 1 day | Orville Jacob AGeneral Manager, New Ventures | SSale | −940 | $79.55 | −$74.8K | −12.6%6.54K after | |
| Feb 16, 2022 (view filing) | Feb 15 | 1 day | Coward D ScottChief Administrative Officer | SSale | −1.81K | $79.55 | −$144.2K | −32.4%3.79K after | |
| Feb 16, 2022 (view filing) | Jun 14, 2021 | 247 days | Condella SarahSVP, Human Resources | SSale | −5.45K | $122.47 | −$667.5K | −6.3%80.5K after | Amended4 lots |
| Nov 3, 2021 (view filing) | Nov 1 | 2 days | Conroy Kevin TPresident and CEO | SSale | −16.9K | $93.88 | −$1.59M | −2.5%664.4K after | |
| Oct 5, 2021 (view filing) | Oct 1 | 4 days | Conroy Kevin TPresident and CEO | SSale | −17.1K | $93.64 | −$1.60M | −2.4%681.3K after | |
| Sep 3, 2021 (view filing) | Sep 1 | 2 days | Conroy Kevin TPresident and CEO | SSale | −19.0K | $104.42 | −$1.98M | −2.6%698.4K after | |
| Aug 4, 2021 (view filing) | Aug 2 | 2 days | Conroy Kevin TPresident and CEO | SSale | −20.0K | $107.50 | −$2.15M | −2.7%717.4K after | |
| Aug 3, 2021 (view filing) | Jul 30 | 4 days | Zanotti Katherine SDirector | SSale | −1.38K | $111.11 | −$153.4K | −3.8%34.7K after | Amended |
| Aug 3, 2021 (view filing) | Jul 30 | 4 days | Doyle James EdwardDirector | SSale | −2.64K | $111.17 | −$293.5K | −8.1%29.8K after | Amended |
| Aug 3, 2021 (view filing) | Jul 29 | 5 days | Elliott Jeffrey ThomasChief Financial Officer | SSale | −38.4K | $111.40 | −$4.27M | −99.5%206 after | Amended8 lots |
| Jul 6, 2021 (view filing) | Jul 1 | 5 days | Conroy Kevin TPresident and CEO | SSale | −7.78K | $123.43 | −$960.8K | −1.0%737.3K after |